Fate Therapeutics
FATE
$4.79
Share price
-4.96%
Change (1 day)
-25.27%
Change (1 year)
Categories
Number of shares outstanding for Fate Therapeutics (FATE)
Number of shares outstanding as of April 2024 : 98,568,012
According to Fate Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 98,568,012. At the end of 2023 the company had 98,568,012 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Fate Therapeutics from 2012 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 98.56 M | 1.39% |
| 2022 | 97.22 M | 1.5% |
| 2021 | 95.78 M | 9.65% |
| 2020 | 87.35 M | 15.56% |
| 2019 | 75.59 M | 17.03% |
| 2018 | 64.59 M | 47.86% |
| 2017 | 43.68 M | 17.38% |
| 2016 | 37.21 M | 29.73% |
| 2015 | 28.68 M | 39.93% |
| 2014 | 20.5 M | 7.02% |
| 2013 | 19.15 M | 116.04% |
| 2012 | 8.86 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | 290,113,000 | 194.33% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | 88,889,000 | -9.82% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | 75,377,997 | -23.53% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | 97,900,000 | -0.68% | 🇺🇸 USA |
 Avidity Biosciences RNA | 74,097,000 | -24.83% | 🇺🇸 USA |